MED News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

ME

Mkt Cap

$134.8M

Volume

90.31K

Next Earnings

October 26th

Chart Financials Earnings News About Insider Filings

Best Momentum Stocks to Buy for October 14thZacks highlights three stocks with Rank #1 buy ratings and strong momentum: Nucor Corporation (steel manufacturing) with 8.6% three-month gains and 6.5% earnings estimate increase; Cinemark Holdings (cinema exhibition) with 29.5% three-month gains and 7.3% earnings estimate increase; and Medifast Inc (weight management) with 10.0% three-month gains and 47.2% earnings estimate increase.Zacks Investment Research · Oct 14, 2026

New Strong Buy Stocks for October 14thFive companies have been added to the Zacks Rank #1 (Strong Buy) list based on significant increases in consensus earnings estimates over the last 60 days. The stocks span multiple sectors including footwear, steel manufacturing, cloud computing, weight management, and insurance.Zacks Investment Research · Oct 14, 2026

Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes?Hormel Foods expanded adjusted operating margins by 60 basis points to 9% in Q3 2026 despite softer retail volumes. The company benefited from lower pork commodity prices, strong foodservice performance, and disciplined cost management. However, retail volumes declined due to business exits and pricing elasticity, while the company faces headwinds from elevated beef, freight, and logistics costs. Hormel is using pricing strategies and efficiency gains to sustain profitability.Zacks Investment Research · Oct 13, 2026

Can Hormel Foods Tackle Input Costs With Pricing and Efficiency?Hormel Foods (HRL) is managing elevated input costs through pricing actions, supply chain improvements, and efficiency gains. While lower pork commodity prices began benefiting in Q3, the company still faces headwinds from higher beef, freight, logistics, and fuel costs. Management expects greater benefits from lower pork costs in future quarters as it implements multiple levers to protect profitability.Zacks Investment Research · Oct 7, 2026

Can Medifast's Better Client Retention Support Revenue Stabilization?Medifast (MED) reported Q2 2026 revenues of $76.4 million, down 27.6% year-over-year due to a 48.7% decline in active earning coaches to 11,700. However, the company showed positive signs with revenue per active coach increasing 41% to $6,529 for a third consecutive quarter, improved client retention, and strong referral program performance. Management expects Q3 revenues of $60-$80 million with continued coach productivity improvements.Zacks Investment Research · Oct 6, 2026

Why Do You Keep Gaining Weight Back After Losing ItTrilivy, a metabolic health system by Medifast, identifies five key factors that drive weight regain: slowed metabolism, hormonal changes, lack of human support, set point theory, and metabolic adaptation. The company's Metabolic Synchronization® framework addresses these through lean mass preservation and visceral fat reduction, with clinical data showing 98% lean mass retention and 14% visceral fat reduction at 16 weeks.GlobeNewswire Inc. · Oct 6, 2026

Will Innovation and Digital Expansion Efforts Drive Clorox's Growth?The Clorox Company is executing a strategic transformation focused on rebuilding market share and enhancing growth through the GOJO Industries acquisition, which significantly expands its health and hygiene portfolio to over half of net sales. The company has completed its five-year digital transformation program and expects productivity benefits from fiscal 2027 onwards. Clorox is increasing innovation spending in health, wellness, and pet care categories while improving brand relevance through targeted promotions and packaging improvements.Zacks Investment Research · Oct 1, 2026

Here's Why Shares of BranchOut Food Surge 89% in a YearBranchOut Food Inc. (BOF) stock has surged 89.1% over the past year, significantly outperforming its industry peers and the broader market. The rally is driven by the company's transition from episodic product launches to recurring retail programs, rapid expansion of its ingredient business, and improving manufacturing utilization. With booked orders providing greater revenue visibility and potential for substantial margin recovery through higher factory utilization, investors are increasingly confident in BOF's ability to leverage its existing infrastructure for higher volumes.Zacks Investment Research · Oct 1, 2026

Hormel Foods Pricing Strategy: Can It Balance Value and Profitability?Hormel Foods executed two pricing rounds that contributed to a 1% decline in total dollar consumption in Q3, while adjusted operating margin improved 60 basis points to 9% and adjusted EPS rose 6% to 37 cents. The company is adapting its portfolio, messaging, pack formats and pricing to address consumers' growing emphasis on value. HRL carries a Zacks Rank #3 (Hold) with a forward P/E of 12.99.Zacks Investment Research · Sep 29, 2026

MNST's International Sales Surge 35%: Is Global Expansion Paying Off?Monster Beverage's international sales jumped 34.6% to $1.16B in Q2 2026, now representing 46% of total sales. Strong growth in EMEA (27.2%), Asia-Pacific (35.7%), and Latin America (56.1%) is driven by product innovation, cooler placements, and Coca-Cola bottler partnerships. However, lower overseas margins and inflation in aluminum, freight, and fuel pose challenges. The stock trades at a premium 36.59X forward P/E, well above the industry average of 19.32X.Zacks Investment Research · Sep 17, 2026

ME

MEDMedifast, Inc.

MED

Pay with—

Available Balance0.00

Your PositionYou don't own any MED yet.

Related Tickers

Earnings